GPER-driven Crosstalk in Breast Cancer: Bridging Drug Resistance and Tumor Microenvironment Remodelling

We are honored to announce that Dr. Tenghua Yu, Associate Chief Physician and Deputy Director of the Breast Surgery Department at Jiangxi Cancer Hospital & Institute, China, will be delivering an Oral Virtual Presentation at the International Conference on Cancer Science and Research, scheduled for November 17–19, 2025, at Village Hotel Changi, Singapore.

Presentation Overview

Triple-negative breast cancer (TNBC) remains one of the most aggressive and challenging forms of breast cancer, marked by poor prognosis and limited treatment options. Dr. Yu’s research sheds new light on the role of G protein-coupled estrogen receptor (GPER) in regulating the tumor microenvironment, particularly its interaction with cancer-associated fibroblasts (CAFs).

His study reveals how estrogen-activated GPER in CAFs stimulates glutamine production through the upregulation of key metabolic enzymes (GLUL and LDHB). This glutamine is then secreted and absorbed by TNBC cells, fueling their growth, motility, and resistance to chemotherapy. By elucidating the GPER/cAMP/PKA/CREB signaling pathway and its impact on metabolic coupling, Dr. Yu identifies GPER as a critical mediator of tumor progression.

The findings emphasize that targeting the estrogen/GPER/glutamine axis could offer promising therapeutic strategies to overcome resistance and suppress TNBC progression. This work highlights the growing importance of metabolic interventions in cancer treatment.

About Dr. Tenghua Yu

Dr. Yu is a dedicated clinician and researcher specializing in breast cancer treatment and tumor microenvironment studies. He earned his PhD from Chongqing Medical University (2013–2016) and furthered his research training at the University of Chicago Medical Center, USA (2024–2025). With more than 30 peer-reviewed publications in esteemed journals such as Oncogene, Clinical and Translational Medicine, and Molecular Cell Endocrinology, Dr. Yu continues to make significant contributions to the field of oncology.



Conference Details

📅 Dates: November 17–19, 2025
📍 Venue: Village Hotel Changi, 1 Netheravon Rd, Singapore 508502
🌐 Website: https://cancer.miconferences.com/
📧 Email: cancer@mathewsconference.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377 0967

Follow us for updates:
🔹 Facebook
🔹 X (Twitter)

#CancerConferences #Oncogene #TraditionalMedicine #CancerResearch #Oncology #Chemotherapy #Cancer2025 #OncologyConferences #GPER #TNBCcells